Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Julphar
Accenture
Chinese Patent Office
Federal Trade Commission
Daiichi Sankyo
Baxter
US Army
Argus Health

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,372,995

« Back to Dashboard

Which drugs does patent 8,372,995 protect, and when does it expire?

Patent 8,372,995 protects TYGACIL and is included in one NDA.

This patent has twenty-seven patent family members in twenty-seven countries.
Summary for Patent: 8,372,995
Title:Crystalline solid forms of tigecycline and methods of preparing same
Abstract: Crystalline solid forms of tigecycline, Form I, Form II, Form III, Form IV, and Form V, compositions comprising these crystalline solid forms, and processes for preparing these crystalline solid forms are described herein.
Inventor(s): Krishnan; Lalitha (Suffern, NY), Deshmukh; Subodh S. (White Plains, NY), Hadfield; Anthony (St. Petersburg, FL), Huang; W. James (Hillsborough, NJ), Ku; Mannching Sherry (Thiells, NY)
Assignee: Wyeth LLC (Madison, NJ)
Application Number:11/440,032
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,372,995
Patent Claim Types:
see list of patent claims
Composition; Process;

Drugs Protected by US Patent 8,372,995

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Pf Prism Cv TYGACIL tigecycline POWDER;IV (INFUSION) 021821-001 Jun 15, 2005 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 8,372,995

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 057649 ➤ Try a Free Trial
Australia 2006251954 ➤ Try a Free Trial
Brazil PI0610653 ➤ Try a Free Trial
Canada 2609875 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Covington
Teva
Cerilliant
Baxter
McKesson
AstraZeneca
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.